Company Filing History:
2 out of 1,743 
2 out of 5,076 
2 out of 11 
Years Active: 2014-2015
Title: Maite Iriarte: Innovator in Vaccine Development
Introduction
Maite Iriarte is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of vaccine development, particularly through her innovative work with modified gram-negative bacteria. With a total of two patents to her name, Iriarte's research focuses on enhancing vaccine efficacy and safety.
Latest Patents
Iriarte's latest patents involve the use of modified gram-negative bacteria as vaccines. The first patent describes Gram-negative bacteria that carry an inactivated gene encoding a glycosyltransferase. This gene is crucial for the synthesis of the core of the lipopolysaccharide (LPS) of these bacteria. The inactivation of this gene leads to the production of a modified LPS core. These modified strains exhibit attenuated virulence while still inducing sufficient humoral immunity to ensure effective vaccination of the host.
Career Highlights
Throughout her career, Maite Iriarte has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Iriarte has collaborated with notable colleagues, including Jean-Pierre Gorvel and Vilma Arce Gorvel. These partnerships have enriched her research and expanded the impact of her innovations in the field of vaccine development.
Conclusion
Maite Iriarte is a trailblazer in the realm of vaccine innovation, with her work on modified gram-negative bacteria paving the way for safer and more effective vaccines. Her contributions to science and medicine continue to inspire future research and development in this critical area.